Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Isodiol International Inc ISOLF

Healthcare Drug Manufacturers - Specialty & Generic Cannabis
Isodiol International Inc is a manufacturer and developer of phytoceutical consumer products using pharmaceutical and nutraceutical grade phytochemical compounds. It generates revenue from the sale of nutritional health products derived from hemp. Geographically, it derives a majority of revenue from the United States and also has a presence in Canada. Its product categories include Tinctures; Capsules; Topicals; Vape; Oral Spray; Skincare; and others.


GREY:ISOLF - Post by User

Isodiol International Inc
Bullboard Posts
User Avatar Image
(0)
•••
Comment by Kinginvestoron Oct 23, 2018 12:00am
68 Views
Post# 28853145

RE:RE:All reports show....

RE:RE:All reports show....You are not good at bashing. Even if ISODIOL ends up a 200mil yearly revenue company which they are on pace for WITHOUT anything becoming a home run product. A 200mil yearly revs would put the fair market valuation at minimum 4-5X current share price. This stock WILL reach those levels. You pointing out how popular CBD is isn't a negative my friend and we don't need the 2 billion market, if we get our 5-10% piece we are GOLDEN
Irie99 wrote: So the entire cbd market might be 2-2.5 billion in 2021.  Virtually every cannabis company going makes cbd products.  I can go to my dispensary in Denver and choose from dozens of products not made by isol.  Ie charlottes web, Mary medicinals, nuleaf, denvercbd, bluebird botanicals, healthworx. Those are just in Colorado. 

Doesnt seem to leave a lot of that 2 billion left if this is supposed to be a ‘unicorn’


Bullboard Posts
Dealroom for high-potential pre-IPO opportunities